MD&A is the same as the prospectus from Nov 15All the risk factors are still the same. Investors gave PAT 46 million at 2.50 based on that prospectus.
I love the negativity on this board right now. Every time it gets like this the stock finds a bottom. And the opposite is true too.. when it gets too bullish on this board we are near a top.
That blurb about revenue is legal jargon that has been in there in every prospectus and md&a. PAT is a growth company whose technology/products will either gain momentum and eventually lead to ridiculous revenues.. or they won’t and the stock will go to zero. With a 260 mill market cap and 80 mill in the bank, a target market that is immense, and a product that could potentially change the world. I personally think as a risk/reward trade this is dirt cheap. Short term revenues are not why you should be in this stock. This is a much bigger story than that. I’m sure investors who financed the company at 2.50 would agree with me.